TickerFactsScreenerDevelopers

Marker Therapeutics, Inc. (MRKR) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

1999: $100.4K2000: $252.2K2001: -$74.0K2002: $465.8K2003: -$643.7K2004: -$2.44M2005: -$2.22M2006: -$3.00M2007: -$1.67M2008: -$3.02M2009: -$1.78M2010: -$3.87M2011: -$3.46M2012: -$6.04M2013: -$8.77M2014: -$1.02M2015: -$21.36M2016: $6.18M2017: $3.66M2018: $59.34M2019: $44.09M2020: $27.34M2021: $43.99M2022: $19.60M2023: $14.05M2024: $18.56M2025: $16.80M$16.80M
1999Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$16.80M-9.5%
2024$18.56M+32.1%
2023$14.05M-28.3%
2022$19.60M-55.4%
2021$43.99M+60.9%
2020$27.34M-38.0%
2019$44.09M-25.7%
2018$59.34M+1522.2%
2017$3.66M-40.9%
2016$6.18M+129.0%
2015-$21.36M-1986.7%
2014-$1.02M+88.3%
2013-$8.77M-45.1%
2012-$6.04M-74.6%
2011-$3.46M+10.5%
2010-$3.87M-116.9%
2009-$1.78M+41.0%
2008-$3.02M-80.5%
2007-$1.67M+44.2%
2006-$3.00M-35.2%
2005-$2.22M+9.0%
2004-$2.44M-279.1%
2003-$643.7K-238.2%
2002$465.8K+729.1%
2001-$74.0K-129.4%
2000$252.2K+151.3%
1999$100.4K—